InspireMD Inc (STU:II2)
€ 0.60 +0.030 (+5.26%) Market Cap: 29.32 Mil Enterprise Value: -4.53 Mil PE Ratio: 0 PB Ratio: 0.76 GF Score: 47/100

Q1 2026 InspireMD Inc Earnings Call Transcript

May 04, 2026 / 08:30PM GMT
Release Date Price: €0.975 (-0.51%)
Operator

Good morning and welcome to InspireMD's first quarter 2026 earnings conference call. Currently, all participants are in listen-only mode. We will facilitate a question-and-answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes. Joining us today from InspireMD are Marvin Slosman, Chief Executive Officer; Mike Lawless, Chief Financial Officer; and Shane Gleason, Chief Commercial Officer.

During this call, management will make forward-looking statements which are based upon management's current expectations, beliefs, and projections, many of which, by their nature, are inherently uncertain. These forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those expressed in such forward-looking statements. More information about these risks. Please refer to the risk factors described in INSPIRES MD's most recently filed periodic report on Form 10-K and Form 10-Q, or any updates in its current report on Form 8-K, filed with the US Securities and Exchange Commission, and INSPIREMD's press

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot